C.R. Bard (BCR) 139.49 $BCR
Bard announces dividend of USD0.21 per share for quarter
M2 - Thu Apr 17, 4:24AM CDT
The board of directors of C R Bard Inc (NYSE:BCR), a developer, manufacturer and marketer of medical technologies, approved a regular quarterly dividend of USD0.21 per share on the company's common stock, it reported on Thursday.
Bard Declares Quarterly Dividend
Business Wire - Wed Apr 16, 3:06PM CDT
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share. The dividend is payable on May 9, 2014 to shareholders of record at the close of business on April 28, 2014.
Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating
M2 - Wed Apr 16, 5:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzpzkc/global_peripheral) has announced the addition of the "Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating" report to their offering. The Global Peripheral I.V. Catheter market to grow at a CAGR of 8.08 percent over the period 2013-2018. The Global Peripheral I.V. Catheter market is driven by several factors, a major one being the increasing aging population. The elderly require peripheral I.V. catheters to deliver drugs and nutrition, and for taking blood samples. Also, WHO statistics state that nearly 2 billion people will be aged 60 years and above by 2050, which will also enhance the market's growth in the future. One of the emerging trends in the market is the adoption of power-injectable closed catheters for the injection of contrast media during CT imaging. CT imaging requires a contrast media to be used for enhanced visualization during diagnostic procedures. However, the catheter must be strong enough to withstand pressures that can be more than 300 psi. Hence, power-injectable closed catheters are used for CT imaging as they are made of polyurethane material, which is much stronger than silicone and can withstand high pressures with a minimal decrease in flexibility. For example, BD Nexiva closed I.V. catheter of BD helps inject contrast media for contrast-enhanced CT scans. Further, the report states that the high cost of integrated/closed catheters is proving to be a hindrance to the adoption of these catheters, particularly in developing countries. Closed catheters are offered at an average selling price of more than US$4, which makes their adoption quite difficult in developing countries. Key Vendors - B. Braun Melsungen AG - Becton, Dickenson and Co. - C.R. Bard Inc. - Smiths Medical - Tangent Medical Technologies - Teleflex Inc. - Terumo Corp. Other Prominent Vendors - Argon Medical Devices Inc. - Medical Components Inc. - Vascular Pathways Inc. - VIGMED AB - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Global Vascular Access Catheter Market Segmentation - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/zz...peripheral
Acquisitions, Trial Study Results, Drug Trend Reports, Conference Call Schedules, and Product Launches - Analyst Notes on Mallinckrodt, Amgen, Express Scripts, CR Bard, and Jazz
PR Newswire - Thu Apr 10, 10:36AM CDT
Today, Analysts Review released its analysts' notes regarding Mallinckrodt plc (NYSE: MNK), Amgen Inc. (NASDAQ: AMGN), Express Scripts Inc. (NASDAQ: ESRX), CR Bard Inc. (NYSE: BCR), and Jazz Pharmaceuticals plc (NASDAQ: JAZZ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Kidney Stones Management Devices Market 2014-2018 with Boston Scientific, Cook Medical, CR Bard, Olympus & Siemens Dominating
M2 - Wed Apr 09, 5:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k43m46/global_kidney) has announced the addition of the "Global Kidney Stones Management Devices Market 2014-2018 with Boston Scientific, Cook Medical, CR Bard, Olympus & Siemens Dominating" report to their offering. The Global Kidney Stones Management Devices market will grow at a CAGR of 4.08 percent over the period 2013-2018. One of the major drivers in this market is the increasing incidence of urolithiasis in the adult population, mostly among the old population. Nearly five million patients are diagnosed with kidney stones worldwide every year. ESWL is the most frequently used procedure for eliminating kidney stones. There is a growing use of this procedure because it is a non-invasive surgery performed by directing shock waves that are created outside the body and passed through skin and tissue to the target area. It is an effective procedure for the removal of kidney stones that are radio-opaque and less than 20 mm in size. ESWL is an outpatient procedure and the patient is able to return to their routine activities almost immediately. The procedure has a minimal analgesic requirement with a reasonable stone clearance rate. Thus, the growing number of ESWL procedures performed is a major trend in the Global Kidney Stones Management Devices market. Further, the report states that one of the major challenges in the market is the adverse effects of lithotripsy shock waves which can often result in hypertension, diabetes, and in some cases permanent loss of functional renal volume. Key Vendors - Boston Scientific Corp. - Cook Medical Inc. - C.R. Bard Inc. - Dornier MedTech GmbH - Olympus Corp. - Siemens Healthcare - STORZ MEDICAL AG Key Market Drivers/Challenges/Trends - Increasing Incidence of Urolithiasis. - Adverse Effects of Lithotripsy Shockwaves. - Growing Number of Extracorporeal Shock Wave Lithotripsy Procedures Being Performed. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Visit http://www.researchandmarkets.com/research/k4...bal_kidney
Look for Shares of CR Bard to Potentially Rebound after Yesterday's 1.80% Sell Off
Comtex SmarTrend(R) - Tue Apr 08, 4:03PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $140.80 to a high of $144.43. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $143.85 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 1.80%, CR Bard Offers Investors Better Value
Comtex SmarTrend(R) - Tue Apr 08, 4:02PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $140.80 to a high of $144.43. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $143.85 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Cardinal Health to Acquire AccessClosure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 1:50PM CDT
Following the announcement, shares of Cardinal Health escalated 1.5% to close at $71.31 yesterday.
New Products, Dividends, Upcoming Conference Calls, and Leadership Changes - Analyst Notes on Intuitive Surgical, Agilent, Bard, St. Jude Medical, and Stryker
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Intuitive Surgical, Inc. (NASDAQ: ISRG), Agilent Technologies Inc. (NYSE: A), C.R. Bard, Inc. (NYSE: BCR), St. Jude Medical, Inc. (NYSE: STJ), and Stryker Corporation (NYSE: SYK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Balanced Risk-Reward for Covidien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 3:40PM CDT
We are impressed with the Covidien's recent fiscal 2014 first quarter results but remains concerned about stiff competition
McKesson's Unit Acquires Stake in Oncology Rehab Partners - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 10:50AM CDT
McKesson Corporation recently announced that its division, McKesson Specialty Health, signed an agreement to acquire a majority stake in Oncology Rehab Partners
CR Bard Touches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 9:10AM CDT
BCR's share price has recorded a healthy return of around 50% over a year's time.
Bard to Host Earnings Conference Call on April 22, 2014
Business Wire - Tue Apr 01, 10:30AM CDT
C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Tuesday, April 22, 2014 at 5:00 PM EDT, to discuss the company's first quarter 2014 operating results, and to provide financial guidance for the second quarter of 2014. Bard is scheduled to issue an earnings press release after the market closes on April 22, 2014.
Becton, Dickinson Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 8:10AM CDT
Becton Dickinson's share price has recorded a healthy return of around 25% over a year.
Healthcare Companies Make Presentations, Submissions, Investigation Extensions, and Expansions - Analyst Notes on CR Bard, Medivation, Align Technology, Covance, and PAREXEL
PR Newswire - Fri Mar 28, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CR Bard Inc. (NYSE: BCR), Medivation, Inc. (NYSE: MDVN), Align Technology Inc. (NASDAQ: ALGN), Covance Inc. (NYSE: CVD), and PAREXEL International Corporation (NASDAQ: PRXL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Global Radiation Therapy Equipment Market 2014-2018: Key Regions, Key Vendors and Key Market Trends
M2 - Wed Mar 26, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2bjnr/global_radiation) has announced the addition of the "Global Radiation Therapy Equipment Market 2014-2018" report to their offering. Radiation therapy equipment is used to perform radiation therapy, also known as radiotherapy or radiation oncology, which is a procedure used in the treatment of cancer. It involves delivering high doses of radiation consisting of photons, electrons or gamma rays to kill cancer cells and reduce the rate at which the cancerous cells multiply by damaging the DNA inside the tumor cells. Radiation therapy is used to treat cancers of the head and neck, bladder, and lung as well as Hodgkin's disease. Radiation therapy can be administered in several ways. The type of therapy prescribed by oncologists depends on factors such as the type of cancer, the stage of the cancer, the size of the tumor, the position of the tumor in the body, the age of the patient, and the patient's medical history. Radiation therapy can either be given independently or in conjunction with other cancer treatments such as surgery and chemotherapy. The analysts forecast the Global Radiation Therapy Equipment market will grow at a CAGR of 6.04 percent over the period 2013-2018. Key Regions - Americas - EMEA - APAC Key Vendors - Accuray Inc. - Elekta AB - Siemens Healthcare - Varian Medical Systems Inc. Other Prominent Vendors - Best Theratronics Ltd. - Brainlab AG - C.R. Bard Inc. - Eckert & Ziegler BEBIG - GE Healthcare Ltd. - Hitachi America Ltd. - Ion Beam Applications SA - Philips Healthcare - RaySearch Laboratories AB Key Market Drivers - Increase in Aging Population. - For a full, detailed list, view our report. For more information visit http://www.researchandmarkets.com/research/v2..._radiation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Bard to Present at the Needham Healthcare Conference
Business Wire - Tue Mar 25, 12:30PM CDT
C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Needham Healthcare Conference in New York City on April 8, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 8:00 AM Eastern Daylight Time.
The Cooper Companies Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 1:50PM CDT
The Cooper Companies has been enjoying rising earnings estimates in the last one month, riding on strong fiscal 2014 first-quarter results and a promising guidance for fiscal 2014.
Covance Crafts New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 9:30AM CDT
On March 20, 2014, shares of Covance reached a new 52-week high of $105.88.
Bard announces dividend of USD0.21 per share for quarter
M2 - Thu Apr 17, 4:24AM CDT
The board of directors of C R Bard Inc (NYSE:BCR), a developer, manufacturer and marketer of medical technologies, approved a regular quarterly dividend of USD0.21 per share on the company's common stock, it reported on Thursday.
Bard Declares Quarterly Dividend
Business Wire - Wed Apr 16, 3:06PM CDT
The Board of Directors of C. R. Bard, Inc. (NYSE:BCR) today declared a regular quarterly dividend of 21 cents per share on Bard's common stock. The current indicated annual dividend rate is 84 cents per share. The dividend is payable on May 9, 2014 to shareholders of record at the close of business on April 28, 2014.
Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating
M2 - Wed Apr 16, 5:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/zzpzkc/global_peripheral) has announced the addition of the "Global Peripheral I.V. Catheter Market 2014-2018 with Braun, CR Bard, Smiths Medical, Teleflex, Terumo & Becton Dickension Dominating" report to their offering. The Global Peripheral I.V. Catheter market to grow at a CAGR of 8.08 percent over the period 2013-2018. The Global Peripheral I.V. Catheter market is driven by several factors, a major one being the increasing aging population. The elderly require peripheral I.V. catheters to deliver drugs and nutrition, and for taking blood samples. Also, WHO statistics state that nearly 2 billion people will be aged 60 years and above by 2050, which will also enhance the market's growth in the future. One of the emerging trends in the market is the adoption of power-injectable closed catheters for the injection of contrast media during CT imaging. CT imaging requires a contrast media to be used for enhanced visualization during diagnostic procedures. However, the catheter must be strong enough to withstand pressures that can be more than 300 psi. Hence, power-injectable closed catheters are used for CT imaging as they are made of polyurethane material, which is much stronger than silicone and can withstand high pressures with a minimal decrease in flexibility. For example, BD Nexiva closed I.V. catheter of BD helps inject contrast media for contrast-enhanced CT scans. Further, the report states that the high cost of integrated/closed catheters is proving to be a hindrance to the adoption of these catheters, particularly in developing countries. Closed catheters are offered at an average selling price of more than US$4, which makes their adoption quite difficult in developing countries. Key Vendors - B. Braun Melsungen AG - Becton, Dickenson and Co. - C.R. Bard Inc. - Smiths Medical - Tangent Medical Technologies - Teleflex Inc. - Terumo Corp. Other Prominent Vendors - Argon Medical Devices Inc. - Medical Components Inc. - Vascular Pathways Inc. - VIGMED AB - Vygon SA Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Global Vascular Access Catheter Market Segmentation - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/zz...peripheral
Acquisitions, Trial Study Results, Drug Trend Reports, Conference Call Schedules, and Product Launches - Analyst Notes on Mallinckrodt, Amgen, Express Scripts, CR Bard, and Jazz
PR Newswire - Thu Apr 10, 10:36AM CDT
Today, Analysts Review released its analysts' notes regarding Mallinckrodt plc (NYSE: MNK), Amgen Inc. (NASDAQ: AMGN), Express Scripts Inc. (NASDAQ: ESRX), CR Bard Inc. (NYSE: BCR), and Jazz Pharmaceuticals plc (NASDAQ: JAZZ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Global Kidney Stones Management Devices Market 2014-2018 with Boston Scientific, Cook Medical, CR Bard, Olympus & Siemens Dominating
M2 - Wed Apr 09, 5:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/k43m46/global_kidney) has announced the addition of the "Global Kidney Stones Management Devices Market 2014-2018 with Boston Scientific, Cook Medical, CR Bard, Olympus & Siemens Dominating" report to their offering. The Global Kidney Stones Management Devices market will grow at a CAGR of 4.08 percent over the period 2013-2018. One of the major drivers in this market is the increasing incidence of urolithiasis in the adult population, mostly among the old population. Nearly five million patients are diagnosed with kidney stones worldwide every year. ESWL is the most frequently used procedure for eliminating kidney stones. There is a growing use of this procedure because it is a non-invasive surgery performed by directing shock waves that are created outside the body and passed through skin and tissue to the target area. It is an effective procedure for the removal of kidney stones that are radio-opaque and less than 20 mm in size. ESWL is an outpatient procedure and the patient is able to return to their routine activities almost immediately. The procedure has a minimal analgesic requirement with a reasonable stone clearance rate. Thus, the growing number of ESWL procedures performed is a major trend in the Global Kidney Stones Management Devices market. Further, the report states that one of the major challenges in the market is the adverse effects of lithotripsy shock waves which can often result in hypertension, diabetes, and in some cases permanent loss of functional renal volume. Key Vendors - Boston Scientific Corp. - Cook Medical Inc. - C.R. Bard Inc. - Dornier MedTech GmbH - Olympus Corp. - Siemens Healthcare - STORZ MEDICAL AG Key Market Drivers/Challenges/Trends - Increasing Incidence of Urolithiasis. - Adverse Effects of Lithotripsy Shockwaves. - Growing Number of Extracorporeal Shock Wave Lithotripsy Procedures Being Performed. Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Product - Market Segmentation by Application - Geographical Segmentation - Buying Criteria - Market Growth Drivers - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis Visit http://www.researchandmarkets.com/research/k4...bal_kidney
Look for Shares of CR Bard to Potentially Rebound after Yesterday's 1.80% Sell Off
Comtex SmarTrend(R) - Tue Apr 08, 4:03PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $140.80 to a high of $144.43. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $143.85 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
After Yesterday's Decline of 1.80%, CR Bard Offers Investors Better Value
Comtex SmarTrend(R) - Tue Apr 08, 4:02PM CDT
CR Bard (NYSE:BCR) traded in a range yesterday that spanned from a low of $140.80 to a high of $144.43. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $143.85 on volume of 1.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Cardinal Health to Acquire AccessClosure - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 1:50PM CDT
Following the announcement, shares of Cardinal Health escalated 1.5% to close at $71.31 yesterday.
New Products, Dividends, Upcoming Conference Calls, and Leadership Changes - Analyst Notes on Intuitive Surgical, Agilent, Bard, St. Jude Medical, and Stryker
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Intuitive Surgical, Inc. (NASDAQ: ISRG), Agilent Technologies Inc. (NYSE: A), C.R. Bard, Inc. (NYSE: BCR), St. Jude Medical, Inc. (NYSE: STJ), and Stryker Corporation (NYSE: SYK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Balanced Risk-Reward for Covidien - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 3:40PM CDT
We are impressed with the Covidien's recent fiscal 2014 first quarter results but remains concerned about stiff competition
McKesson's Unit Acquires Stake in Oncology Rehab Partners - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 10:50AM CDT
McKesson Corporation recently announced that its division, McKesson Specialty Health, signed an agreement to acquire a majority stake in Oncology Rehab Partners
CR Bard Touches New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 9:10AM CDT
BCR's share price has recorded a healthy return of around 50% over a year's time.
Bard to Host Earnings Conference Call on April 22, 2014
Business Wire - Tue Apr 01, 10:30AM CDT
C. R. Bard, Inc. (NYSE:BCR) today announced that it will host a conference call on Tuesday, April 22, 2014 at 5:00 PM EDT, to discuss the company's first quarter 2014 operating results, and to provide financial guidance for the second quarter of 2014. Bard is scheduled to issue an earnings press release after the market closes on April 22, 2014.
Becton, Dickinson Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 01, 8:10AM CDT
Becton Dickinson's share price has recorded a healthy return of around 25% over a year.
Healthcare Companies Make Presentations, Submissions, Investigation Extensions, and Expansions - Analyst Notes on CR Bard, Medivation, Align Technology, Covance, and PAREXEL
PR Newswire - Fri Mar 28, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding CR Bard Inc. (NYSE: BCR), Medivation, Inc. (NYSE: MDVN), Align Technology Inc. (NASDAQ: ALGN), Covance Inc. (NYSE: CVD), and PAREXEL International Corporation (NASDAQ: PRXL). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
STAAR Surgical (STAA) in Focus: Stock Rises 6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Mar 26, 7:57AM CDT
STAAR Surgical Company (STAA) was a big mover last session, as the company saw its shares rise nearly 6% on the day.
Global Radiation Therapy Equipment Market 2014-2018: Key Regions, Key Vendors and Key Market Trends
M2 - Wed Mar 26, 5:18AM CDT
Research and Markets (http://www.researchandmarkets.com/research/v2bjnr/global_radiation) has announced the addition of the "Global Radiation Therapy Equipment Market 2014-2018" report to their offering. Radiation therapy equipment is used to perform radiation therapy, also known as radiotherapy or radiation oncology, which is a procedure used in the treatment of cancer. It involves delivering high doses of radiation consisting of photons, electrons or gamma rays to kill cancer cells and reduce the rate at which the cancerous cells multiply by damaging the DNA inside the tumor cells. Radiation therapy is used to treat cancers of the head and neck, bladder, and lung as well as Hodgkin's disease. Radiation therapy can be administered in several ways. The type of therapy prescribed by oncologists depends on factors such as the type of cancer, the stage of the cancer, the size of the tumor, the position of the tumor in the body, the age of the patient, and the patient's medical history. Radiation therapy can either be given independently or in conjunction with other cancer treatments such as surgery and chemotherapy. The analysts forecast the Global Radiation Therapy Equipment market will grow at a CAGR of 6.04 percent over the period 2013-2018. Key Regions - Americas - EMEA - APAC Key Vendors - Accuray Inc. - Elekta AB - Siemens Healthcare - Varian Medical Systems Inc. Other Prominent Vendors - Best Theratronics Ltd. - Brainlab AG - C.R. Bard Inc. - Eckert & Ziegler BEBIG - GE Healthcare Ltd. - Hitachi America Ltd. - Ion Beam Applications SA - Philips Healthcare - RaySearch Laboratories AB Key Market Drivers - Increase in Aging Population. - For a full, detailed list, view our report. For more information visit http://www.researchandmarkets.com/research/v2..._radiation About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Bard to Present at the Needham Healthcare Conference
Business Wire - Tue Mar 25, 12:30PM CDT
C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Needham Healthcare Conference in New York City on April 8, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the company in a presentation scheduled to begin at 8:00 AM Eastern Daylight Time.
The Cooper Companies Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 1:50PM CDT
The Cooper Companies has been enjoying rising earnings estimates in the last one month, riding on strong fiscal 2014 first-quarter results and a promising guidance for fiscal 2014.
Covance Crafts New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 21, 9:30AM CDT
On March 20, 2014, shares of Covance reached a new 52-week high of $105.88.
